Table Of Content

CONTENTS Volume 10 Issue Nos 1-6 HEMATOLOGICAL ONCOLOGY Issue No. 1 January-February 1992 Special Issue: Current Cancer Therapy Editor’s Note. 1 Advances in Current Cancer Treatment: An Overview: G. H. Lyman and A. S. D. Spiers 3 Current Approaches to Small Cell Lung Cancer: J. Aisner. 7 Adjuvant Therapy of Non-Small Cell Lung Cancer: E. Carmack Holmes. 21 Chemotherapy of Metastatic Non-Small Cell Carcinoma of the Lung: J. C. Ruckdeschel. 25 Gastric Cancer—Surgical Approach: J. L. Weese and M. L. Nussbaum. 31 Gastric Cancer: Chemotherapy of Advanced Disease: J. S. Macdonald. 37 Advances in the Chemotherapy of Gynecologic Malignancies: R. F. Ozols. 43 Future Directions in the Management ofSoft Tissue Sarcomas: A. D. Elias .... 53 Ifosfamide, Carboplatin, and Etoposide in Combination for Induction and High-dose Chemotherapy: Focus on Breast Cancer and Lymphoma: K. K. Fields, G. J. Elfenbein, R. A. Saleh, P. E. Zorsky, W. E. Janssen, J. B. Perkins, T. G. Saleh, J. T. Piazza, L. E. Kronish, M. C. Machak and G. H. Lyman. 61 Issue No. 2 March-April 1992 Specific Cutaneous Involvement in Hodgkin’s Disease: D. Tassies, J. Sierra, E. Montserrat, R. Marti, T. Estrach and C. Rozman. 75 Failure of IMVP-16 as Second-line Treatment for Relapsed or Refractory High Grade Non-Hodgkin’s Lymphoma: C. De Lord, A. C. Newland, D. C. Linch, B. Vaughan Hudson and G. Vaughan Hudson. 81 Etoposide in Combination with Intermediate Dose Cytosine Arabinoside (ID ARA C) Given with the Intention of Further Myeloablative Therapy for the Treatment of Refractory or Recurrent Hematological Malignancy: J. S. Whelan, C. L. Davis, A. Z. S. Rohatiner, M. Leahy, P. K. MacCallum, R. K. Gupta, J. Matthews, A. J. Norton, J. A. L. Amess and T. A. Lister. 87 A New Monoclonal Antibody Which Binds to the Cytoplasm of Large Cell Lymph¬ omas: N. Nakamura, S. Suzuki, N. Ono, K. Tominaga, H. Hojo, M. Abe and H. Wakasa. 95 Intensive Retreatment of Adults and Children with Acute Lymphoblastic Leukemia: R. Bassan, P. E. Cornelli, R. Battista, F. Terzi, M. Buelli, A. Rambaldi, P. Viero, A. D’Emilio, E. Dini and T. Barbui. 105 Comparative Pharmacokinetic Study of Idarubicin and Daunorubicin in Leukemia Patients: J. Robert, F. Rigal-Huguet and P. Hurteloup. Ill Effects of Recombinant Human Interferon-Alpha, Beta and Gamma on the Anti¬ proliferative Activity of Cytarabine in K562 Human Myeloid Leukemia Clonogenic Cells: H. T. Hassan, C. Tsiriyotis and H. R. Maurer. 117 The Biological and Clinical Significance of the Kl-67 Growth Fraction in Multiple Myeloma: J. Drach, C. Gattringer, H. Glassl, D. Drach and H. Huber.125 Issue No. 3/4 May-August 1992 RESEARCH ARTICLES The Prognostic Factors for Peripheral T-cell Lymphomas: R. Liang, S. L. Loke and A.C. L.Chan. 135 Angiocentric T-cell Lymphoma of the Nose, Paranasal Sinuses and Hard Palate: A. Aviles, L. Rodriguez, R. Guzman, A. Talavera, E. L. Garcia and J. C. Diaz-Maqueo 141 Detection of Immunoglubulin Gene Rearrangement in B-cell Lymphomas by Polymer¬ ase Chain Reaction Gene Amplification: R. Liang, V. Chan, T. K. Chan, T. Wong and D.Todd. 149 PAPERS Intensive Chemotherapy for Peripheral T-cell Lymphomas: R. Liang, D. Todd, T. K. Chan, E. Chiu, A. Lie, F. C. S. Ho and S. L. Loke. 155 Proliferation in Non-Hodgkin’s Lymphomas as Determined by Immunohistochemical Double Staining for Ki-67: K. Tominaga, Y. Yamaguchi, Y. Nozawa, M. Abe and H. Wakasa. 163 ‘Aggressive’ Low Grade Lymphocytic Lymphomas can be Identified by Flow Cyto¬ metric S-Phase Determinations: J. Lindh, H. Jonsson, P. Lenner and G. Roos . . . 171 Bone Mineral Density (BMD) in Patients with Lymphoma: The Effects of Chemo¬ therapy, Intermittent Corticosteroids and Premature Menopause: M. A. Ratcliffe, S. A. Lanham, D. M. Reid and A. A. Dawson. 181 Expression of Leukocyte Adhesion Molecules (ICAM-l/LFA-1) Related to Clinical Behaviour in B Cell Lymphomas: Y. Nozawa, Y. Yamaguchi, K. Tominaga, H. Hojo, M. Abe and H. Wakasa. 189 In Vitro Differentiation of a Hodgkin’s Disease Derived Cell Line: S. Klein, D. B. Jones and H. Tesch. 195 Solitary Plasmacytoma of Bone: Clinical Features, Treatment and Survival: P. A. Ellis and B. M. Colls.207 Expression of pi 70 Protein in Multiple Myeloma: a Clinical Study: G. Ucci, M. Petrini, A. Riccardi, R. Invernizzi, G. Carulli, R. Luoni, M. Giordano and M. Danova 213 Acute Myelogenous Leukemia (AML) and Diabetes Insipidus (DI): Further Association with Monsomy 7: S. E. Slater, P. K. Maccallum, F. Birjandi, B. Gibbons and T. A. Lister. 221 Verapamil Preferentially Potentiates In-vitro Cytotoxicity of Vincristine on Malignant Lymphoid Cells: I. A. Malik and N. V. Costea.225 BOOK REVIEWS.233 ANNOUNCEMENTS. i Issue No. 5 September-October 1992 Role of Blast Cell Immunophenotyping for the Diagnosis and Prognosis of Acute Myeloid Leukemia: N. Dubosc-Marchenay, F. Lacombe, P. Dumain, G. Marit, M. Montastruc, F. Belloc and J. Reiffers.235 The Management of Acute Myelogenous Leukemia in the Elderly: Ten-Year Experience in 118 Patients: R. Bassan, M. Buelli, P. Viero, C. Minotti and T. Barbui.251 Large Cell Lymphoma with Initial Presentation in the Bone Marrow: K. F. Wong, J. K. C. Chan, C. S. Ng, Y. C. Chu, L. P. K. Li and C. H. Chan.261 Accumulation of p53 Protein Correlates with Tumour Proliferative Activity in EBV Positive Burkitt’s Lymphoma: T. Lehtinen, J. Isola, R. Aine, M. Alavaikko and M. Lehtinen.273 BOOK REVIEWS.281 BIBLIOGRAPHY.283 Issue No. 6 November-December 1992 RESEARCH ARTICLE Protein Kinase C Isozyme Expression in Human Leukemia-Lymphoma Cell Lines—An Immunocytochemical Study: H. Hojo, Y. Morimura, M. Abe, K. Tominaga, Y. Nozawa, N. Nakamura, N. Ono, K. Tasaki, Y. Yamaguchi, S. Suzuki and H. Wakasa 295 PAPERS Mitoxantrone and Intermediate-Dose Cytosine Arabinoside for Poor-risk Acute Leukemias: Response to Treatment and Factors Influencing Outcome: J. Sierra, A. Granena, F. Bosch, E. Carreras, J-M. Marti, A. Urbano-Ispizua, M. Rovira and C. Rozman.301 A Pilot Study of ChlOpHEPP-B—A Weekly Regimen for Patients with Untreated Advanced or Recurrent Hodgkin’s Disease: G. M. Smith, D. Wright, J. A. Child, A. V. Simmons, D. R. Norfolk, D. L. Barnard, D. Parker and L. Parapia .... 311 Production of Multiple Cytokines by Hodgkin’s Disease Derived Cell Lines: S. Klein, M. Jiicker, V. Diehl and H. Tesch.319 Cytophagic Histiocytic Panniculitis: A Diagnostic Dilemma: P-L. Cheah, L-M. Looi, P-E. Tan, J. Bosco and P. Kuperan.331 CASE STUDY Prognostic Significance of Karyotype Analysis in Children with Acute Lymphoblastic Leukemia: R. Ankathil, J. Stephen, D. M. Vasudevan, P. Kusumakumary, G. Rajasekharan Pillai and M. Krishnan Nair. 339 CURRENT AWARENESS IN HEMATOLOGICAL ONCOLOGY.345 AUTHOR INDEX. i KEY WORD INDEX. iii VOLUME CONTENTS. vii Cf' ■ L t i I